[1]
J. M. Dayno, MD, G. Niebler, DO, J. Lawler, BS, T. Elhauge, MSc, and K. Lindhardt, MSc, PhD, DBE, “Clinical relevance of the pharmacokinetic characteristics of an abuse-deterrent, extended-release, injection-molded morphine tablet”, J of Opioid Management, vol. 13, no. 2, pp. 111–124, Mar. 2017.